BIOQUAL, Inc.

BIOQUAL, Inc. provides pre-clinical research services, both in-vivo (using living organisms) and in-vitro (using non-living components), to commercial and government clients within the United States. The company offers contract research services focusing on various infectious diseases, including AIDS, influenza, respiratory syncytial virus, Coronavirus, malaria, hepatitis, and flavivirus infections such as Zika and dengue, as well as cancer. BIOQUAL also develops and utilizes small and large animal models for research. Its service offerings extend to cell-based assays, immunoassay, toxicology and cytotoxicity testing, and viral load testing. The company also provides tailored assay development services, Biocontainment facilities, imaging services, and animal model development. Furthermore, BIOQUAL offers IND-enabling services, which include toxicology studies, pharmacokinetic profiling, GLP (Good Laboratory Practice) services, and regulatory documentation services. BIOQUAL, Inc. was incorporated in 1981 and operates from Rockville, Maryland.